Clinical Trial Update: Minimally-Invasive Cardiovascular Hemodynamic Optimization (MiCHO) Versus Early Goal-Directed Therapy (EGDT) in the Management of Septic Shock [Phase 4]

View source ↗

Summary

Phase 4 trial comparing Minimally-Invasive Cardiovascular Hemodynamic Optimization (MiCHO) to Early Goal-Directed Therapy (EGDT) in septic shock; the study was …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Sepsis
• Septic Shock

Snippet

Sponsor: Loma Linda University | Conditions: Severe Sepsis, Septic Shock | Phase 4 | Status: TERMINATED | Results posted: 2014-06-25